| dc.contributor.author | Purcell, Gregory | |
| dc.contributor.author | McCartney, Jane | |
| dc.contributor.author | Boschmans, Shirley-Anne | |
| dc.date.accessioned | 2023-06-07T07:42:39Z | |
| dc.date.available | 2023-06-07T07:42:39Z | |
| dc.date.issued | 2019 | |
| dc.identifier.citation | Purcell, G. et al. (2019). Documentation of antipsychotic-related adverse drug reactions: An educational intervention. South African Journal of Psychiatry, 25, a1378. https://doi.org/10.4102/sajpsychiatry.v25i0.1378 | en_US |
| dc.identifier.issn | 2078-6786 | |
| dc.identifier.uri | https://doi.org/10.4102/sajpsychiatry.v25i0.1378 | |
| dc.identifier.uri | http://hdl.handle.net/10566/9050 | |
| dc.description.abstract | Antipsychotic agents are associated with harmful adverse reactions which
impact negatively on patient adherence and clinical management. Accurate and complete
documentation of signs and symptoms in the clinical notes is an important means of
communication between healthcare providers, and an essential component in the management
of antipsychotic-induced adverse drug reactions. To determine the impact of an educational intervention on the incidence and extent of
antipsychotic-induced adverse drug reaction documentation in patient medical records. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | AOSIS | en_US |
| dc.subject | Antipsychotics | en_US |
| dc.subject | Pharmaceuticals | en_US |
| dc.subject | Psychotic disorders | en_US |
| dc.subject | Psychiatric disorders | en_US |
| dc.subject | Clinical management | en_US |
| dc.title | Documentation of antipsychotic-related adverse drug reactions: An educational intervention | en_US |
| dc.type | Article | en_US |
